^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    JNJ-26483327

    i
    Other names: JNJ-26483327
    Associations
    News
    Trials
    Company:
    J&J
    Drug class:
    EGFR inhibitor, HER2 inhibitor, HER4 inhibitor, Src kinase inhibitor, RET inhibitor, VEGFR-3 inhibitor
    Related drugs:
    Associations
    News
    Trials